FMR CORP 13D and 13G filings for Terns Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 10:05 am Sale |
2024-02-08 | 13G | Terns Pharmaceuticals, Inc. TERN |
FMR CORP | 2,990,402 4.839% |
-2,127,648 (-41.57%) |
Filing |
| 2023-10-13 3:58 pm Sale |
2023-10-09 | 13G | Terns Pharmaceuticals, Inc. TERN |
FMR CORP | 5,118,050 8.380% |
-2,260,591 (-30.64%) |
Filing |
| 2023-02-09 12:39 pm Purchase |
2023-02-09 | 13G | Terns Pharmaceuticals, Inc. TERN |
FMR CORP | 7,378,641 14.901% |
1,736,567 (+30.78%) |
Filing |
| 2022-12-12 08:41 am Purchase |
2022-12-09 | 13G | Terns Pharmaceuticals, Inc. TERN |
FMR CORP | 5,642,074 14.999% |
5,539,780 (+5415.55%) |
Filing |
| 2022-06-10 11:04 am Sale |
2022-06-09 | 13G | Terns Pharmaceuticals, Inc. TERN |
FMR CORP | 102,294 0.404% |
-2,698,691 (-96.35%) |
Filing |
| 2022-02-09 10:01 am Sale |
2022-02-08 | 13G | Terns Pharmaceuticals, Inc. TERN |
FMR CORP | 2,800,985 11.085% |
-86,753 (-3.00%) |
Filing |
| 2021-04-12 1:05 pm Purchase |
2021-04-09 | 13G | Terns Pharmaceuticals, Inc. TERN |
FMR CORP | 2,887,738 11.493% |
2,887,738 (New Position) |
Filing |